Centre for Vascular Research, University of New South Wales, Sydney NSW 2052, Australia.
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):536-45. doi: 10.1161/ATVBAHA.109.193821. Epub 2009 Dec 17.
The transcription factor early growth response (EGR)-1 has been implicated as a key vascular phenotypic switch through its control of inducible transcription. EGR-1 autoregulation, and histone modification in the EGR-1 promoter, represent key mechanisms in EGR-1 control, but have not been explored.
We demonstrate that EGR-1 regulates its own transcription and that this involves histone H3 phosphorylation and acetylation. EGR-1 transactivates its promoter in smooth muscle cells exposed to interleukin (IL) 1beta through a novel cis-acting element (-211/-203). PD98059, which inhibits mitogen-activated protein kinase kinase/extracellular regulated kinase (MEK/ERK) attenuates IL-1beta-inducible phosphorylation of extracellular signal-regulated kinase 1/2 and mitogen and stress-activated protein kinases 1/2; and reduces levels of phosphorylated and acetylated histone H3. Histone deacetylase inhibition enhances EGR-1 transcription in response to cytokine. Conversely, suppression of histone modification with mitogen and stress-activated protein kinase 1/2 short interfering RNA, or the histone H3 acetyltransferase inhibitor Garcinol, inhibits IL-1beta-inducible EGR-1 transcription. EGR-1 interacts with the acetyltransferase p300. Acetylated H3 and phosphorylated H3 are enriched at the promoter of EGR-1; and EGR-1 is enriched at the promoters of tissue factor and plasminogen activator inhibitor 1 in response to IL-1beta, and attenuated by PD98059, Garcinol, and mitogen and stress-activated protein kinase 1/2 short interfering RNA.
IL-1beta induction of EGR-1 transcription involves histone H3 phosphorylation, acetylation, and autoregulation by EGR-1.
转录因子早期生长反应(EGR)-1 已被认为是通过其对诱导转录的控制来实现血管表型转换的关键因素。EGR-1 自身调控及其启动子中的组蛋白修饰是 EGR-1 调控的关键机制,但尚未得到探索。
我们证明 EGR-1 调节自身转录,这涉及组蛋白 H3 的磷酸化和乙酰化。在暴露于白细胞介素(IL)1β的平滑肌细胞中,EGR-1 通过一个新的顺式作用元件(-211/-203)反式激活其启动子。PD98059,一种抑制丝裂原活化蛋白激酶激酶/细胞外调节激酶(MEK/ERK)的药物,可减弱 IL-1β诱导的细胞外信号调节激酶 1/2 和丝裂原和应激激活蛋白激酶 1/2 的磷酸化;并降低磷酸化和乙酰化组蛋白 H3 的水平。组蛋白去乙酰化酶抑制可增强细胞因子对 EGR-1 转录的作用。相反,用丝裂原和应激激活蛋白激酶 1/2 短发夹 RNA 抑制组蛋白修饰,或用组蛋白 H3 乙酰转移酶抑制剂 Garcinol 抑制,均可抑制 IL-1β诱导的 EGR-1 转录。EGR-1 与乙酰转移酶 p300 相互作用。乙酰化 H3 和磷酸化 H3 在 EGR-1 启动子处富集;并且 EGR-1 在组织因子和纤溶酶原激活物抑制剂 1 的启动子处富集,对 IL-1β的反应被 PD98059、Garcinol 和丝裂原和应激激活蛋白激酶 1/2 短发夹 RNA 减弱。
IL-1β诱导的 EGR-1 转录涉及组蛋白 H3 的磷酸化、乙酰化和 EGR-1 的自身调控。